Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bodmer

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Therapeutic Drug Monitoring|January 29, 2008
Pharmacokinetics of midazolam and metabolites in a patient with refractory status epilepticus treated with extraordinary doses of midazolamMichael Bodmer, Bettina Link, Nathalie Grignaschi, et al.
Drug Safety|August 17, 2018
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control StudyNoel Frey, Michael Bodmer, Andreas Bircher, et al.
Planta Medica|March 14, 2012
Heat exposure of Cannabis sativa extracts affects the pharmacokinetic and metabolic profile in healthy male subjectsMartin Eichler, Luca Spinedi, Sandra Unfer-Grauwiler, et al.
Archives of Internal Medicine|April 30, 2008
Use of thiazolidinediones and fracture riskChristian Meier, Marius E Kraenzlin, Michael Bodmer, et al.
Swiss Medical Weekly|May 11, 2012
Diuretic use, RAAS blockade and morbidity in elderly patients presenting to the Emergency Department with non-specific complaintsJuliane M Ruedinger, Christian H Nickel, Silke Maile, et al.
British Journal of Clinical Pharmacology|June 10, 2008
Pharmacokinetics of intravenous and oral midazolam in plasma and saliva in humans: usefulness of saliva as matrix for CYP3A phenotypingBettina Link, Manuel Haschke, Nathalie Grignaschi, et al.
Clinical Toxicology (Philadelphia, Pa.)|November 9, 2013
Gastric pharmacobezoars in quetiapine extended-release overdose: a case seriesChristine Rauber-Lüthy, Katharina E Hofer, Michael Bodmer, et al.
The Journal of Investigative Dermatology|February 17, 2017
The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UKNoel Frey, Janine Jossi, Michael Bodmer, et al.
Epilepsia|October 14, 2017
The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugsNoel Frey, Michael Bodmer, Andreas Bircher, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 22, 2009
Comparison of the dissolution and pharmacokinetic profiles of two galenical formulations of the endothelin receptor antagonist macitentanOliver Kummer, Manuel Haschke, Felix Hammann, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Therapeutic Drug Monitoring|January 29, 2008
Pharmacokinetics of midazolam and metabolites in a patient with refractory status epilepticus treated with extraordinary doses of midazolamMichael Bodmer, Bettina Link, Nathalie Grignaschi, et al.
Drug Safety|August 17, 2018
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control StudyNoel Frey, Michael Bodmer, Andreas Bircher, et al.
Planta Medica|March 14, 2012
Heat exposure of Cannabis sativa extracts affects the pharmacokinetic and metabolic profile in healthy male subjectsMartin Eichler, Luca Spinedi, Sandra Unfer-Grauwiler, et al.
Archives of Internal Medicine|April 30, 2008
Use of thiazolidinediones and fracture riskChristian Meier, Marius E Kraenzlin, Michael Bodmer, et al.
Swiss Medical Weekly|May 11, 2012
Diuretic use, RAAS blockade and morbidity in elderly patients presenting to the Emergency Department with non-specific complaintsJuliane M Ruedinger, Christian H Nickel, Silke Maile, et al.
British Journal of Clinical Pharmacology|June 10, 2008
Pharmacokinetics of intravenous and oral midazolam in plasma and saliva in humans: usefulness of saliva as matrix for CYP3A phenotypingBettina Link, Manuel Haschke, Nathalie Grignaschi, et al.
Clinical Toxicology (Philadelphia, Pa.)|November 9, 2013
Gastric pharmacobezoars in quetiapine extended-release overdose: a case seriesChristine Rauber-Lüthy, Katharina E Hofer, Michael Bodmer, et al.
The Journal of Investigative Dermatology|February 17, 2017
The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UKNoel Frey, Janine Jossi, Michael Bodmer, et al.
Epilepsia|October 14, 2017
The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugsNoel Frey, Michael Bodmer, Andreas Bircher, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 22, 2009
Comparison of the dissolution and pharmacokinetic profiles of two galenical formulations of the endothelin receptor antagonist macitentanOliver Kummer, Manuel Haschke, Felix Hammann, et al.
Pageof 8